copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Cardiac amyloidosis: Treatment and prognosis - UpToDate Amyloid deposits can occur in a variety of organs, but morbidity and mortality from amyloid deposition most commonly occur when the heart, kidney, liver, or autonomic nervous system are affected (See "Overview of amyloidosis" ) This topic will review the treatment and prognosis of cardiac amyloidosis
Cardiac Amyloidosis Clinic - Overview - Mayo Clinic A team approach At the Cardiac Amyloidosis Clinic, doctors who specialize in blood conditions (hematologists), the heart (cardiologists), imaging (radiologists), anatomic pathology, computational biology, neurology, nephrology and hypertension, and other areas work together to provide excellent, comprehensive care
Focus on Heart Failure | Cardiac Amyloidosis: Seek and Ye May . . . Cardiac amyloidosis is becoming increasingly recognized as an etiology for heart failure (HF) Most cases of amyloid cardiomyopathy will fall into one of two categories: light-chain amyloid (AL) amyloidosis resulting from misfolding of monoclonal immunoglobulin light chains or transthyretin
Cardiac amyloidosis | SIU Medicine Cardiac amyloidosis can do undiagnosed or misdiagnosed for years as it can mimic other conditions Cardiac amyloidosis is a progressive disease and early diagnosis is critical in altering the course of the disease It is important to talk to specialists in the field if you have symptoms of amyloidosis like congestive heart failure, shortness of breath, irregular heart rhythm, neuropathy
FOCUS on Cardiac Amyloidosis - European Society of Cardiology Cardiac amyloidosis is a progressive disease caused by the extracellular deposition of amyloid fibrils in the heart More frequent than previously believed, it contributes to many common clinical scenarios such as severe aortic stenosis, increased left ventricular wall thickness and heart failure with preserved ejection fraction
Heart Failure Management of Patients with Amyloid . . . Abstract Cardiac amyloidosis (CA) can lead to progressive heart failure (HF) by depositing insoluble amyloid fibrils within the myocardial extracellular space, resulting in an infiltrative and restrictive cardiomyopathy Although CA was previously perceived as rare and incurable, recent advances in diagnostics and emerging therapies have been changing this outlook It is crucial to spread